INDUSTRY NEWS
In December 2021, Biogen cut the price of Spinraza (Nusinersen Sodium Injection) from 700,000 yuan per dose to 33,000 yuan per dose. The move was for …
China officially permits Shenzhen to pilot the online sales of prescription drugs, according to the market-access-relaxing measures released by Nation…
On January 5, 2022, the Work Safety Committee of the State Council issued the National Plan for Centralized Management of Safety Risks of Hazardous Ch…
Companies may no longer manufacture under Temporary Guidance beyond December 31, 2021 The Temporary Emergency Use Authorization (EUA) on hand sanitize…
On December 1, 2021, China began to enact the national standard, “GB 38456-2020 Hygienic Requirements for Antibacterial and Bacteriostatic Lotion”. Th…
On October 21st and 22nd 2021, the Chinese Ministry of Agricultural and Rural Affairs concluded the 6th session of the 9th Review Committee of Fertili…
In China, many patients resort to unconventional means of receiving treatment for their diseases, like going abroad or relying on surrogate shoppers. …
China National Medical Products Administration (NMPA) officially issued the Good Pharmacovigilance Practices (GVP) on May 13, 2021, after releasing th…
According to China’s Administrative Measures for Drug Registration enacted since July 1, 2020, the National Medical Products Administration (NMP…
China’s drug review & approval system has undergone substantial reforms since it joined the ICH (International Council for Harmonisation of …